メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
富山大学 ホーム
日本語
English
ホーム
プロファイル
研究部門
設備
プロジェクト
研究成果
データセット
受賞
活動
授業
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
林 伸彦
助教, 博士（医学） 金沢医科大学 2006年3月
内科学（第三）講座
h-index
463
被引用数
12
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2007
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(37)
類似のプロファイル
(2)
フィンガープリント
Nobuhiko Hayashiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
4-hydroxynonenal (4-HNE)
33%
5′-untranslated Region (5′-UTR)
32%
Advanced Glycation End Products
30%
Alcoholic Liver Disease
43%
Aphthous Stomatitis
30%
Binge Drinking
30%
Colonic Cancer
30%
Confidence Interval
50%
Cytochrome P450 2E1 (CYP2E1)
31%
Diabetic Dyslipidemia
30%
Ethanol
80%
Ethanol Intake
32%
Functional Dyspepsia
30%
Gastroduodenal Diseases
30%
Genetic Polymorphism
91%
GGsTop
50%
Glutamyl Transpeptidase
34%
Hepatic Ischemia-reperfusion Injury
60%
Hepatitis C Virus
55%
Hepatocellular Carcinoma
94%
High Mobility Group Box 1 (HMGB1)
37%
IL-17F
30%
Image Fusion System
30%
Interleukin-17 (IL-17)
60%
Interleukin-6
60%
Irsogladine Maleate
30%
Ischemia-reperfusion Injury
30%
Japan
31%
Limy Bile
30%
Liver
33%
Meta-analysis
45%
MicroRNA-325
30%
Necrosis
42%
NF1 Gene
30%
Non-alcoholic Fatty Liver Disease (NAFLD)
35%
Nonalcoholic Steatohepatitis
30%
Obesity
38%
Odds Ratio
56%
Oxidative Stress
30%
Pancreatic Fluid Collections
60%
Polymorphism
47%
Pre-microRNA
60%
Radiofrequency Ablation
60%
Recurrent Aphthous Stomatitis
30%
Risk Factors
31%
Rs2275913
43%
Simple Steatosis
30%
SLC6A4
30%
Therapeutic Effect
36%
Walled-off
31%
Pharmacology, Toxicology and Pharmaceutical Science
1,1 Dimethylhydrazine
30%
4 Hydroxynonenal
29%
Acetylsalicylic Acid
10%
Advanced Glycation End Product
30%
Adverse Event
25%
Alanine Aminotransferase
9%
Alcohol Liver Disease
46%
Alcoholic Fatty Liver
36%
Aphthous Stomatitis
30%
Aspartate Aminotransferase
9%
Biological Marker
30%
Chronic Hepatitis
30%
Colon Carcinoma
30%
Cytochrome
28%
Delirium
30%
Diabetes Mellitus
30%
Duodenum Disease
30%
Dyslipidemia
30%
Ethanol
53%
Fatty Liver
52%
Fibrosis
28%
Gamma Glutamyltransferase
82%
Hepatitis C
30%
Hepatitis C Virus
40%
Interleukin 17
30%
Interleukin 6
30%
Irsogladine Maleate
30%
Ischemia
72%
Jejunum Ulcer
30%
Liver Cell Carcinoma
33%
Liver Fibrosis
30%
Liver Ischemia
60%
Liver Necrosis
11%
Neoplasm
34%
Non-Steroidal Anti-Inflammatory Drug
10%
Nonalcoholic Fatty Liver
60%
Normal Human
17%
Opiate
10%
Osteopontin
30%
Otsuka Long Evans Tokushima Fatty Rat
33%
Pancreas Cancer
30%
Peginterferon
30%
Pharmacotherapy
10%
Recombinant Thrombomodulin
30%
Reperfusion Injury
60%
Ribavirin
30%
Steatosis
35%
Therapeutic Effect
33%
Tissue Injury
30%
Tumor Necrosis Factor
10%
Medicine and Dentistry
4 Hydroxynonenal
25%
Acute Pancreatitis
17%
Advanced Glycation End-Product
30%
Adverse Event
30%
Adverse Outcome
19%
Alcohol
33%
Alcohol Consumption
30%
Alcohol Liver Disease
46%
Alcoholic Fatty Liver
33%
Balloon Dilatation
30%
Celiac Plexus
30%
Charlson Comorbidity Index
17%
Chronic Hepatitis
30%
Common Bile Duct
25%
Common Bile Duct Stone
20%
Comorbidity
20%
Cytochrome
20%
Delirium
30%
Diabetes Mellitus
30%
Dyslipidemia
30%
Echography
30%
Endoscopic Retrograde Cholangiopancreatography
20%
Endoscopic Ultrasound
100%
Fatty Liver
30%
Fine-Needle Aspiration
15%
Gamma-Glutamyl Transpeptidase
33%
Gastrectomy
16%
Hepatocellular Carcinoma
60%
Hepatocyte
15%
Infection
17%
Interleukin 6
30%
Ischemia
30%
Limy Bile
30%
Mesothelioma
30%
Necrosis
70%
Neoplasm
20%
Nonalcoholic Fatty Liver
60%
Obstructive Jaundice
30%
Odds Ratio
36%
Oxidative Stress
30%
Pancreas Cancer
30%
Pancreas Pseudocyst
16%
Pancreas Tumor
30%
Radiofrequency Ablation
60%
Randomized Controlled Trial
20%
Steatosis
35%
Systematic Review
15%
Therapy Effect
32%
Thrombocytosis
30%
Tissue Injury
30%
